Pitt-Hopkins-Like Syndrome 1
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
|
21827697 |
2011 |
Pitt-Hopkins-Like Syndrome 1
|
0.900 |
Biomarker
|
disease |
MGD |
Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits.
|
21962519 |
2011 |
Pitt-Hopkins-Like Syndrome 1
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.
|
16571880 |
2006 |
Pitt-Hopkins-Like Syndrome 1
|
0.900 |
GermlineCausalMutation
|
disease |
ORPHANET |
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.
|
16571880 |
2006 |
Pitt-Hopkins-Like Syndrome 1
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Possible case of Pitt-Hopkins syndrome in sibs.
|
11568923 |
2001 |
Pitt-Hopkins-Like Syndrome 1
|
0.900 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cortical dysplasia with focal epilepsy syndrome
|
0.810 |
Biomarker
|
disease |
BEFREE |
CNTNAP2 was first implicated in the cortical dysplasia-focal epilepsy (CDFE) syndrome, a recessive disease characterized by intellectual disability, epilepsy, language impairments and autistic features.
|
30586385 |
2018 |
Cortical dysplasia with focal epilepsy syndrome
|
0.810 |
Biomarker
|
disease |
MGD |
Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits.
|
21962519 |
2011 |
Cortical dysplasia with focal epilepsy syndrome
|
0.810 |
GermlineCausalMutation
|
disease |
ORPHANET |
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.
|
16571880 |
2006 |
Cortical dysplasia with focal epilepsy syndrome
|
0.810 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.
|
16571880 |
2006 |
Cortical dysplasia with focal epilepsy syndrome
|
0.810 |
Biomarker
|
disease |
CTD_human |
|
|
|
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
The loss of CNTNAP2 function leads to autism spectrum disorder in humans and to autistic behaviours in mice.
|
31653345 |
2020 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
We show a paternally inherited miR-873-5p variant with altered binding affinity for several risk-genes including NRXN2 and CNTNAP2 putatively overlay maternally inherited loss-of-function coding variations in NRXN1 and CNTNAP2 to likely increase the genetic liability in an idiopathic ASD case.
|
29703944 |
2019 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
Mice deficient in Cntnap2 (Cntnap2-/- mice) show core ASD-like phenotypes, and have been demonstrated as a validated model for ASD-relevant drug discovery.
|
30816216 |
2019 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
Some studies indicated the association of CNTNAP2 with ASD, while others reported no association.
|
30681286 |
2019 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
Targeted resequencing of 358 candidate genes for autism spectrum disorder in a Chinese cohort reveals diagnostic potential and genotype-phenotype correlations.
|
30763456 |
2019 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Loss-of-function mutations in CNTNAP2 cause a syndromic form of autism spectrum disorder in humans and produce social deficits, repetitive behaviors, and seizures in mice.
|
31141683 |
2019 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
In this review, we provide a summary of animal and cellular models for three genes linked to ADHD and ASD in human patients - CNTNAP2, ADGRL3, and PARK2.
|
30376466 |
2019 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These findings reveal a key contribution of ASD-associated gene CNTNAP2 in modulating macroscale functional connectivity, and suggest that homozygous loss-of-function mutations in this gene may predispose to neurodevelopmental disorders and autism through a selective dysregulation of connectivity in integrative prefrontal areas.
|
28184409 |
2018 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Loss of one Cntnap2 allele is sufficient to elicit axonal growth alteration, revealing a situation that may be relevant for CNTNAP2 heterozygosity in ASD patients.
|
29788201 |
2018 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Human autoantibodies to contactin-associated protein-like 2 (CASPR2) are often associated with neuropathic pain, and CASPR2 mutations have been linked to autism spectrum disorders, in which sensory dysfunction is increasingly recognized.
|
29429934 |
2018 |
Autism Spectrum Disorders
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Considering that Cntnap2 shows high expression levels in the striatum during human and mouse embryonic development and that the cortico-striato-thalamic circuitry is important for speech and language development, alterations in striatal PV expression and associated (homeostatic) adaptations are likely to play an important role in <i>Cntnap2-/-</i> mice and, assumingly, in human ASD patients with known Cntnap2 mutations.
|
30116174 |
2018 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We also tested the effects of 4 human CNTNAP2 ASD missense mutations in vivo, and found that they impaired PV+ CIN development.
|
29028946 |
2018 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
Employing yeast two-hybrid screening, biochemical analysis, in situ proximity ligation assay (PLA), SIM, and phenotype rescue, we show that these effects are mediated at the membrane by the interaction of CNTNAP2's C-terminus with calcium/calmodulin-dependent serine protein kinase (CASK), another ASD/ID risk gene.
|
29610457 |
2018 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
Contactin-associated protein-like 2 (<i>CNTNAP2</i>) is an ASD-associated gene, and while <i>Cntnap2</i> knockout (KO) mice recapitulate many of the features of ASD, the effect on cortical circuitry is poorly understood.
|
28115996 |
2017 |